Market Overview:
The global oligonucleotide market is expected to reach USD XX million by 2030, at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for nucleic acids in various applications such as gene chips, electrophoresis, and fluorescence in situ hybridization (FISH). Additionally, the increasing focus on personalized medicine is also propelling the growth of this market. However, stringent regulatory norms and high costs associated with R&D are restraining the growth of this market. On the basis of type, DNA oligonucleotides accounted for a major share of the global oligonucleotide market in 2017. This segment is expected to grow at a CAGR of XX% during 2018-2030 owing to its wide range of applications across different industries.
Product Definition:
An oligonucleotide is a short DNA or RNA molecule. It is usually used as a drug or diagnostic agent.
DNA:
Oligonucleotide is a short string of nucleotides, which are used as an important tool in molecular biology. DNA (deoxyribonucleic acid) is the primary material for gene expression and genetic engineering. Oligonucleotide plays an important role in controlling cellular processes such as apoptosis, differentiation, cell proliferation & division, gene silencing and DNA-based therapy. It also helps regulate the immune system by acting as a antigen stimulating factor inside cells.
RNA:
RNA (Ribonucleic Acid) is a nucleic acid with the basic structure of deoxyribonucleotide triphosphate. It carries information from DNA and it's used as a structural component in all living organisms. RNA plays an important role in the molecular biology for protein synthesis, gene silencing, cell development & differentiation, apoptosis regulation & signal transduction pathways.
Application Insights:
Gene chip was the largest application segment in terms of revenue generation in 2017. Gene chip is used for genetic analysis and diagnosis. It plays a vital role in medical research as it helps identify mutations & abnormalities associated with diseases. Thus, gene chips are widely used for disease diagnosis and related research activities across the globe owing to their low cost, high efficiency and easy handling characteristics.
Electrophoresis is anticipated to be the fastest growing application segment over the forecast period owing to its wide-spread use during DNA sequencing procedures as well as other diagnostic tests such as polymerase chain reaction (PCR). Owing to its ability to separate DNA fragments on account of their charge or mobility, it has become an essential tool for various applications including drug development & toxicology testing at clinical level among others.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of research laboratories involved in oligonucleotide research and development, along with substantial funding from government agencies for such projects. The U.S., being one of the most lucrative markets for pharmaceuticals, has also witnessed significant investment by major players in drug discovery & development activities over the past few years. As a result, there is an increasing demand for products across various applications such as gene chip analysis and electrophoresis that require high purity and high quality DNA or RNA samples.
Asia Pacific is expected to witness exponential growth during the forecast period owing to rising healthcare expenditure coupled with growing awareness regarding genetic disorders & cancer among people living in this region especially those who are from India & China (excluding Hong Kong).
Growth Factors:
- Increasing demand for personalized medicines
- Rising prevalence of target diseases
- Growing number of clinical trials
- Technological advancements in oligonucleotide synthesis and delivery
- Increasing investment in R&D
Scope Of The Report
Report Attributes
Report Details
Report Title
Oligonucleotide Market Research Report
By Type
DNA, RNA
By Application
Gene Chip, Electrophoresis, Fluorescence In Situ Hybridization
By Companies
Abbott Molecular, PerkinElmer, SciGene Corporation, Roche NimbleGen, CytoTest
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
210
Number of Tables & Figures
147
Customization Available
Yes, the report can be customized as per your need.
Global Oligonucleotide Market Report Segments:
The global Oligonucleotide market is segmented on the basis of:
Types
DNA, RNA
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Gene Chip, Electrophoresis, Fluorescence In Situ Hybridization
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Molecular
- PerkinElmer
- SciGene Corporation
- Roche NimbleGen
- CytoTest
Highlights of The Oligonucleotide Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DNA
- RNA
- By Application:
- Gene Chip
- Electrophoresis
- Fluorescence In Situ Hybridization
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oligonucleotide Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oligonucleotide is a molecule made up of two or more nucleotides.
Some of the major companies in the oligonucleotide market are Abbott Molecular, PerkinElmer, SciGene Corporation, Roche NimbleGen, CytoTest.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Oligonucleotide Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Oligonucleotide Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Oligonucleotide Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Oligonucleotide Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Oligonucleotide Market Size & Forecast, 2020-2028
4.5.1 Oligonucleotide Market Size and Y-o-Y Growth
4.5.2 Oligonucleotide Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 DNA
5.2.2 RNA
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Gene Chip
6.2.2 Electrophoresis
6.2.3 Fluorescence In Situ Hybridization
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Oligonucleotide Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Oligonucleotide Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 DNA
9.6.2 RNA
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Gene Chip
9.10.2 Electrophoresis
9.10.3 Fluorescence In Situ Hybridization
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 DNA
10.6.2 RNA
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Gene Chip
10.10.2 Electrophoresis
10.10.3 Fluorescence In Situ Hybridization
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 DNA
11.6.2 RNA
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Gene Chip
11.10.2 Electrophoresis
11.10.3 Fluorescence In Situ Hybridization
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 DNA
12.6.2 RNA
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Gene Chip
12.10.2 Electrophoresis
12.10.3 Fluorescence In Situ Hybridization
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 DNA
13.6.2 RNA
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Gene Chip
13.10.2 Electrophoresis
13.10.3 Fluorescence In Situ Hybridization
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Oligonucleotide Market: Competitive Dashboard
14.2 Global Oligonucleotide Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Molecular
14.3.2 PerkinElmer
14.3.3 SciGene Corporation
14.3.4 Roche NimbleGen
14.3.5 CytoTest
